The Legality of Marijuana in Spain and the Possibility of Home Cultivation: Insights from the Medical Marijuana Program Connection Marijuana,...
FDA Approves First Cell Therapy for Solid Tumors, Marking a Significant Milestone In a groundbreaking development, the U.S. Food and...
The Inflation Reduction Act for Clinical Research Professionals (ACRP) is a significant piece of legislation that aims to address the...
Sylvester Comprehensive Cancer Center, a leading cancer research and treatment facility, has recently announced the appointment of Dr. Emily Thompson...
Gilead Sciences, a leading biopharmaceutical company, has recently announced that it will be conducting a thorough review of a drug...
Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...
The Potential of Cannabidiol as a Treatment for Different Substance Use Disorders Substance use disorders, including addiction to drugs and...
Activation of the cardiac α-myosin heavy chain (α-MHC) gene editing has emerged as a promising approach to induce positive inotropy...
The Importance of Clinical Trial Diversity Highlighted by Black History Month Black History Month is a time to celebrate the...
FDA Endorses Tricuspid Regurgitation Device Following Positive Findings in TRILUMINATE Clinical Trial Tricuspid regurgitation (TR) is a condition where the...
Title: Unveiling the Role of Neurofibromin 1 in Regulating Metabolic Balance and Notch-Dependent Quiescence of Murine Juvenile Myogenic Progenitors Introduction:...
Neurona Therapeutics, a biotechnology company focused on developing cell therapies for neurological disorders, has recently announced securing $120 million in...
Using Microrobots Controlled by a Magnetic Field for the Treatment of Liver Cancer Liver cancer is a serious and potentially...
AstraZeneca, a leading global pharmaceutical company, has recently announced its plans to invest $300 million in building a new facility...
Phase IIb trial results have recently revealed that Tozorakimab, a potential treatment for diabetic kidney disease (DKD), did not meet...
